January 20, 2026
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and…
Pharmaceuticals, Biotechnology and Life Sciences
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and…
Full-year 2025 revenue reached €1,465m : +7.9% at constant exchange rate and scope (CERS) vs 2024+4.8% at actual rates impacted…
WALTHAM, Mass., Jan. 19, 2026 (GLOBE NEWSWIRE) — BVI, a global leader in the ophthalmic device market, announced today the…
TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”),…
KUALA LUMPUR, Malaysia, Jan. 19, 2026 (GLOBE NEWSWIRE) — CUKTECH has officially announced the launch of its flagship product, the…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…
CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) — Concept Life Sciences, a leading global contract research organization (CRO) specialising…
COPENHAGEN, Denmark, January 19, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on…
Approval Label May Include Opioid ReductionNEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA…